Opportunistic pathogen pseudomonas aeruginosa UCBPP-PA14's transcriptome
To explore the mechanism of the azithromycin mediated repression of resistance development. Based on the goal, we treated wild type pseudomonas aeruginosa UCBPP-PA14 with 3 mg/L ceftazidime-avibactam, 16 mg/L azithromycin alone or in combination for 3 hours before collecting samples for transcriptome analysis.